000045345 000__ 01130cam\a22003855i\4500
000045345 001__ 45345
000045345 003__ SzGeWIPO
000045345 005__ 20240708150109.0
000045345 006__ m\\\\eo\\d\\\\\\\\
000045345 007__ cr bn |||m|||a
000045345 008__ 220324s2021\\\\nyu\\\\\o\\\\\000\0\eng\d
000045345 035__ $$a(OCoLC)1313806491
000045345 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045345 041__ $$aeng
000045345 24500 $$aHow Much is too Much? Anti-counterfeit Measures and Access to Medicines in the East African Community.
000045345 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2021
000045345 300__ $$a1 online resource
000045345 336__ $$atext$$2rdacontent
000045345 337__ $$acomputer$$2rdamedia
000045345 338__ $$aonline resource$$bcr$$2rdacarrier
000045345 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 43, Issue 9
000045345 542__ $$fhttps://1.next.westlaw.com/Copyright
000045345 588__ $$aCrossref
000045345 590__ $$aPublished online: 2021
000045345 650_0 $$aIntellectual property$$zAfrica
000045345 650_0 $$aTrade Related Aspects of Intellectual Property (TRIPS)
000045345 650_0 $$aPharmaceutical industry
000045345 7001_ $$aOlatunji, Olugbenga A.,$$eauthor.
000045345 7731_ $$tEuropean Intellectual Property Review
000045345 7731_ $$wEIPR
000045345 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2021, 43(9), 594-608
000045345 85641 $$uhttps://www.westlaw.com/Document/I5AA2D3D0F71011EBA0E7B72A4547540F/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000045345 904__ $$aJournal article
000045345 980__ $$aEIPR